Possible 業務改善指示 against ギリアド・サイエンシズ インク
For developers: integration details
You do not need this for normal browsing. Use it when integrating this enforcement record into an internal tool or AI workflow.
/api/v1/enforcements?company=%E3%82%AE%E3%83%AA%E3%82%A2%E3%83%89%E3%83%BB%E3%82%B5%E3%82%A4%E3%82%A8%E3%83%B3%E3%82%B7%E3%82%BA%20%E3%82%A4%E3%83%B3%E3%82%AF&limit=10Action summary
- Company
- ギリアド・サイエンシズ インクJapanese originalOriginal: ギリアド・サイエンシズ インク
- Entity match
- Possible entity match60/100Machine extractedCompany name extracted from the Japanese public disclosure
- Governing law
- 医薬品医療機器法医薬品医療機器法
- Action type
- 業務改善指示業務改善指示
- Action date
- 13 February 2015
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
During the clinical trial commissioned by the company, the company did not report adverse reactions that occurred post-marketing abroad within the specified deadline.
Show original Japanese text
同社が依頼を行った治験の実施中に、国外で市販後に発生した副作用を定められた期限内に報告しなかった
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Japanese regulatory disclosure under 医薬品医療機器法.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-25T00:04:48.953+00:00
- Evidence checked
- 2026-04-25T00:04:48.953+00:00
- Archive captured
- 2026-04-04T06:01:09.843+00:00
Show audit JSON
{
"record": {
"id": "ea126e0c-c802-4e76-8ca4-9c5ae7cf8a8d",
"url": "https://regbase.jp/en/enforcement/other-giriadosaiensizuinku-20150213",
"company_name_original": "ギリアド・サイエンシズ インク",
"company_name_registry": "ギリアド・サイエンシズ インク",
"corporate_number": null,
"law": {
"ja": "医薬品医療機器法",
"en": "医薬品医療機器法"
},
"action_type": {
"ja": "業務改善指示",
"en": "業務改善指示"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "possible",
"confidence": 60,
"method": "extracted_japanese_name",
"method_label": "Company name extracted from the Japanese public disclosure",
"notes": null
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Context needed",
"actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
"practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
"lawContext": "Japanese regulatory disclosure under 医薬品医療機器法."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-giriadosaiensizuinku-20150213",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000073914.html",
"archiveUrl": "https://kiroku.today/view/e89e3e0c36jxcgim",
"archiveCapturedAt": "2026-04-04T06:01:09.843+00:00",
"extractedAt": "2026-04-25T00:04:48.953+00:00",
"translatedAt": "2026-05-01T06:55:05.707+00:00",
"evidenceCheckedAt": "2026-04-25T00:04:48.953+00:00",
"generatedAt": "2026-05-20T23:50:44.981Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)Company info
- English name
- ギリアド・サイエンシズ インク Japanese original
- Japanese name
- ギリアド・サイエンシズ インク
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.